Changes in characteristics of rat skeletal muscle after experimental allergic encephalomyelitis. by Haan, A. de et al.
ABSTRACT: Experimental allergic encephalomyelitis (EAE) serves as an
animal model for certain neuroinﬂammatory diseases of the central nervous
system, in particular multiple sclerosis (MS). EAE is accompanied by tran-
sient weakness or paralysis of hind limbs. We have investigated the effect of
partial and transient conduction failure in the central nervous system on
skeletal muscle function. At2.5 days after development of maximal clinical
signs, body and medial gastrocnemius muscle mass were lower (by 21
and 33%, respectively; P  0.05) in EAE rats compared with controls. Fiber
cross-sectional area was lower by 40–50% in all ﬁber types. Maximal force
and power were substantially lower (by 58% and 73%) in EAE rats, as was
the force normalized for muscle mass (35%). However, no such weakness
was found when lower stimulation frequencies were used. Generation of
similar submaximal forces was attributable to a slower relaxation in EAE
muscles. This advantage for the EAE muscles was lost during repeated
exercise. While fatigability was similar, the difference in relaxation rate
between EAE and control disappeared in fatigue. Our data suggest that, as
a result of central neuroinﬂammatory diseases, maximal performance of
skeletal muscle is impaired but submaximal performance is relatively well
maintained.
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Muscle weakness23 and fatigue30 are important
symptoms in patients with multiple sclerosis (MS).
The type and extent of neurological deﬁcits in MS
vary from attack to attack.21 During the disease, dam-
age and recovery occur both simultaneously and
serially. The therapeutic possibilities for MS are lim-
ited, and new approaches to inﬂuence the balance
between damage and recovery are needed. This is
true not only for the demyelinating process, but also
for the muscle weakness resulting from the patho-
logical events in the central nervous system.
Apart from the neurologically induced changes in
the skeletal muscles, peripheral symptoms may be a
consequence of chronically reduced physical activity in
MS patients.19 Relatively small changes in ﬁber-type
composition and a decreased oxidative capacity are
indications of adaptation to reduced activity.16 The
lower maximal force–generating capacity of quadri-
ceps muscles of MS patients compared to controls 9
may be related to partial atrophy of the muscle ﬁbers
due to reduced activity, but may also be an indication
of a lower speciﬁc force (force per cross-sectional area)
due to reduced activity or to MS-related neurological
deﬁcits. However, these ﬁndings probably explain only
part of the weakness of MS patients. It has been sug-
gested that muscle weakness in MS patients is mainly a
result of an impaired voluntary activation of skeletal
muscles and that enhanced fatigability results from the
higher relative workload of MS patients at the same
absolute load, e.g., with carrying their own weight.9
Experimental allergic encephalomyelitis (EAE) is
an experimental inﬂammatory demyelinating dis-
Abbreviations: CFA, complete Freunds adjuvant; CSA, cross-sectional
area; EAE, experimental allergic encephalomyelitis; GM, gastrocnemius me-
dialis; Lo, muscle optimum length; MBP, myelin basic protein; MS, multiple
sclerosis
Key words: experimental allergic encephalomyelitis; fatigue; MS; muscle
atrophy; muscle weakness
Correspondence to: A. de Haan; e-mail: a.dehaan@fbw.vu.nl
© 2004 Wiley Periodicals, Inc.
Muscle Function in Acute EAE MUSCLE & NERVE March 2004 369
ease of the central nervous system, and serves as an
animal model to study demyelinating diseases of the
central nervous system in general, and MS in partic-
ular.24,25 In the induction phase (days 1–10), animals
are immunized with myelin components to induce
an anti-myelin immune response.22,25 In particular,
the effector phase of EAE (days 10–18), during
which local inﬂammatory responses cause the actual
tissue damage, is relevant for studying the damaging
events in MS. Acute actively induced EAE in Lewis
rats is characterized by a temporal paresis and paral-
ysis of hind limbs and tail.22 To our knowledge, no
reports are available on the effect of the immune-
mediated, transient, and probably partial central
conduction failure on the properties of the muscu-
lature in EAE rats. In this study, we therefore exam-
ined whether changes in skeletal muscle function
occur in EAE animals and the nature of any changes.
Accordingly, muscle performance and several mus-
cle characteristics were measured in EAE during the
recovery phase of the paralytic episode, and com-
pared to those of control rats.
MATERIALS AND METHODS
Experiments were performed using 15 male Lewis
rats. Acute EAE was induced in seven rats by a single
subcutaneous injection of puriﬁed myelin basic pro-
tein (MBP) in combination with Mycobacterium tuber-
culosis (37 Hra, Difco, Detroit, MI) and complete
Freunds adjuvant (CFA; Difco) under ether anesthe-
sia.22 Four rats were injected only with CFA (without
MBP) and served as control. Another four control
rats received no treatment. The EAE and CFA rats
were weighed daily and examined for the develop-
ment of neurological signs. Clinical signs were
scored on a scale from 0 to 4: 0, no clinical signs; 0.5,
loss of body mass; 1.0, loss of tip of tail reﬂex; 1.5,
complete loss of tail tonus; 2.0 unsteady gait; 2.5,
paresis of the hind legs; 3.0, complete paralysis of the
hind legs; 3.5, paralysis of the complete lower part of
the body; 4.0, death due to EAE.22 Experiments on
muscle function were performed 15–18 days after
immunization (or CFA), 2–3 days after the peak of
the disease.
The rats were anaesthetized with an initial dose
of urethane (1.5 g/kg; i.p). Supplementary injec-
tions (0.63 g/kg) were applied if necessary. Medial
gastrocnemius (GM) muscles were freed from the
surrounding tissue, and the distal tendon with a
small part of the calcaneus was connected to a force
transducer that was part of an isovelocity measuring
system.6 The proximal origin of the GM was left
intact, as was its blood supply. The femur was ﬁxed to
the measuring system. Length changes of the GM
were induced by a servomotor connected to the lever
arm to which the force transducer was mounted.
Contractions were induced by electrical stimulation
(pulse width, 50 s) of the sciatic nerve with only the
branches leading to the GM left unimpaired. The
current amplitude (0.5 mA) was high enough to
activate all muscle ﬁbers. To prevent the (reﬂex)
inﬂuence of the nervous system, the sciatic nerve was
severed as proximal as possible and the distal part
was stimulated. The muscle temperature was main-
tained at 34–36°C with a water-saturated airﬂow
around the muscle, which also kept the muscle
moistened. Stimulation and length changes were
computer controlled. Force and length signals were
digitized (1 or 10 kHz) and stored on disc of the
same computer. At the end of the experiments, the
GM was excised, weighed, stretched to about opti-
mum length, and frozen in isopentane cooled in
liquid nitrogen, and the rats were killed with an
overdose of anesthesia.
Rat handling and experiments conformed with
the Dutch Research Council’s guide for the care and
use of laboratory animals.
Protocols. For all muscles, optimum length was ﬁrst
estimated using a few twitch contractions (1 per
min). Optimum length (Lo) was then determined
with only a few (three to four) tetanic contractions
(stimulation frequency, 150 Hz; duration, 150 ms).
About 15 min later, the following protocols were
started.
Force–Velocity Relation. For the measurements
of the force–velocity relation, the muscles were max-
imally stimulated with a frequency of 400 Hz to
ensure maximal activation at all velocities.10 Contrac-
tions were performed during which the muscles were
allowed to shorten at a constant velocity (varying
from 0–200 mm/s with 10 mm/s intervals). Just
before the contraction, the muscle was passively
stretched to a length 0.5–1 mm above Lo. Each
contraction started with a short isometric phase (du-
ration varying from 10 to 30 ms) during which the
force increased to the level that could be sustained
during the subsequent shortening at the speciﬁc
imposed velocity. In this way, the measured force was
constant when the muscle passed Lo during short-
ening.7 Between contractions, there was at least
2-min rest.
Stimulation Frequency–Force Relation. The inﬂu-
ence of stimulation frequency on isometric force
production was measured using the following fre-
quencies: 20, between 40 and 160 at 10-Hz intervals,
180, 200, and 250 Hz. The stimulation duration was
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150 ms. Recovery time between contractions was at
least 1.5 min.
Fatigue. Finally, the muscles underwent a fa-
tigue protocol. This protocol consisted of a series of
20 repeated isometric contractions (stimulation fre-
quency, 150 Hz; duration, 150 ms; 1 contraction
every 500 ms).
Analysis of Muscle Samples. Three consecutive
cross-sections (10 m) were cut at mid-level of each
GM. One section was stained for connective tissue by
incubation in a Sirius Red F3B medium as described
by Sant’Ana Pereira et al.29 The two other cross-
sections were stained for myosin adenosinetriphos-
phatase (mATPase) after alkaline (pH 10.4)13 and
acid (pH 4.7)1 preincubation.
The cross-sections were digitized and analyzed
using a Carl Zeiss KS400 image analysis system with
custom-made software. The system consists of a light
microscope (Axioskop H; Zeiss, Weesp, The Nether-
lands), on which a digital camera (Axiocam MRc
color version; Zeiss) is mounted. Cross-sections were
scanned and divided in an array of 10  10 subsec-
tions; each of the subsections was digitized (resolu-
tion 800  800 pixels) using a 10 objective and
stored as a JPEG ﬁle for further analysis.
The images stained for connective tissue were
used to create a mask to identify the same ﬁbers in
the serial cross-sections. The cross-sections of GM
can be separated in two regions: one containing all
ﬁber types in the proximal part of the muscle, and
one containing only type IIX and IIB ﬁbers, located
predominantly in the distal part of the muscle.11 For
both regions of each muscle, an area containing
about 75 ﬁbers was selected for analysis. Cross-
sectional areas (CSA) of the selected ﬁbers were
obtained from the mask images. Classiﬁcation of
ﬁber type occurred by combination of the two mAT-
Pase stainings.29 Six ﬁber groups were identiﬁed:
types I, IIA, IIX, and IIB in the proximal region, and
types IIX and IIB in the distal region.
Data Analysis. For all isometric contractions, peak
force and half-relaxation time were calculated. Half-
relaxation time was taken as the time for force to
decrease from the maximum to 50% of the maxi-
mum at the end of stimulation. To account for dif-
ferences in muscle mass between groups of rats, the
maximal isometric force was also calculated per
gram of muscle. The force decrease during the fa-
tigue protocol was expressed relative to the force of
the ﬁrst contraction.
For each muscle, a curve was ﬁtted through the
force–velocity data points using the Hill equation.
From the ﬁtted curves, maximal shortening velocity,
maximal power, and the curvature (a/Fo) were cal-
culated, where Fo is the force of the ﬁtted curve at
zero velocity.
The total number of ﬁbers from each type per
region (proximal or distal) in all analyzed muscles
was determined for the EAE and control groups.
From these numbers, the ﬁber-type distribution was
calculated for each region in both groups. The cross-
sectional areas of ﬁber types were averaged for each
muscle. Mean ( SEM) CSA was then calculated for
the EAE and control groups.
Statistics. Differences between mean data  stan-
dard deviation for the groups were tested using Stu-
dent’s t-tests. Differences between the stimulation
frequency–force relations of the groups were tested
using ANOVA repeated measures (P  0.05). In the
case of signiﬁcant main effects, a Bonferroni post-
hoc analysis was performed. A two-way (ﬁber type
and group) ANOVA was performed to test for dif-
ferences with respect to ﬁber area (P  0.05).
RESULTS
The experiments with CFA treatment were included
in the study as placebo control of possible effects of
the anesthesia and treatment procedures. As ex-
pected, the animals showed no clinical signs and all
data for muscles of CFA-treated rats (n  4) were
similar to the control rats without any treatment
(n  4). Since there was no indication of an inﬂu-
ence of treatment procedures on any parameter, all
data for control animals were pooled into one com-
bined group (control; n  8).
All EAE rats showed a lower activity level in their
cages due to paralysis of their hind-limb muscles at
the peak of the disease. The average maximal score
was 2.8  0.6 (mean  SD), which maximum was
obtained 14.1  0.6 days after injection. The mea-
surements of the muscle characteristics were per-
formed 2.5 1.1 days after the day with the maximal
score when the score had decreased to 1.6  1.0.
Only one rat still had a paralysis of the hind-limb
muscles on the day of the measurements.
Body and Muscle Mass. There was a signiﬁcant dif-
ference in body mass of the rats between the EAE
and control groups (Table 1). This was a result of a
signiﬁcant decrease in body mass of rats in the EAE
group from 292  18 g (10 days after the injection)
to 240  26 g (at the day of the experiment; n  8).
For comparison, the body mass of the CFA-treated
rats increased signiﬁcantly from day 10 to day 15
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from 286  25 g to 309  17 g (n  4). The loss of
body mass in the EAE group (by 21%) was at least
partly due to a loss of muscle mass (for the medial
gastrocnemius muscle by 33%; Table 1).
Fiber-Type Distribution and Area. There were freez-
ing artifacts in the cross-sections of one muscle of the
combined control group. As a result, analysis was
performed in seven muscles of each group. Table 2
shows that the number of ﬁbers analyzed per type
and the ﬁber-type distribution of both the proximal
and distal region were not different between the
EAE and control groups. The cross-sectional area of
all ﬁber types was 40–50% lower (P  0.05) in the
EAE group than the control group.
Functional Characteristics. Maximal Isometric Con-
tractions. The maximal isometric force of the EAE
group was dramatically lower (by 58%; P  0.05)
than the control group (Table 1). This lower force
was not due only to the loss of muscle mass, because
the force normalized for muscle mass was also sig-
niﬁcantly lower (by 35%; P  0.05). This is illus-
trated by average force traces of both groups in
Figure 1. The ﬁgure further shows that the relax-
ation of the muscles was slower in the EAE group,
which is indicated by the signiﬁcantly longer half-
relaxation time (Table 1).
Force–Velocity Characteristics. Group averaged
values ( SD) of parameters obtained from the
force–velocity curve for each muscle are given in
Table 1. The maximal shortening velocity was not
Table 1. Mean (SD) of rat and medial gastrocnemius muscle
characteristics of the EAE and control groups.
Control
(n  8)
EAE
(n  7)
Body mass (g) 305  31 240  26*
Muscle mass (mg) 783  100 528  110*
Maximal isometric
force (Fmax) (N) 13.3  1.3 5.6  1.6*
Fmax/muscle mass
(N/mg) 17.0  1.2 11.0  3.2*
Half-relaxation time
(ms) 39  4 51  7*
Maximal shortening
velocity (mm/s) 227  36 242  48
Maximal power
(mW) 387  48 106  40*
Force–velocity
curvature (a/Fo) 0.64  0.27 0.21  0.04*
EAE, experimental allergic encephalomyelitis.
*Indicates signiﬁcant difference between the EAE and control groups (P 
0.05).
Table 2. Fiber type number, distribution, and cross-sectional area in the proximal and distal regions of medial gastrocnemius
muscles of EAE and control rats.†
Fiber type
Number (n) Distribution (%) Cross-sectional area (m2)
Control EAE Control EAE Control EAE
Proximal region
Type I 94 104 17.3 19.0 1,472  134 929  79*
Type IIA 113 110 20.8 20.1 1,336  129 788  80*
Type IIX 253 287 46.5 52.2 1,796  126 1,032  126*
Type IIB 84 46 15.4 8.4 2,347  153 1,254  163*
Distal region
Type IIX 143 139 25.2 25.5 1,539  137 903  144*
Type IIB 424 406 74.8 74.5 2,624  211 1,223  212*
EAE, experimental allergic encephalomyelitis.
†There were seven rats in both the control and EAE groups.
*Indicates signiﬁcant difference between the EAE and control groups (P  0.05).
FIGURE 1. Average force traces of a maximal tetanic contraction
(150 HZ; 150 ms) of medial gastrocnemius muscles of EAE
(dashed line) and control (solid line) rats. The force traces are
normalized per gram muscle mass and averaged for seven EAE
muscles and eight control muscles.
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signiﬁcantly different between groups. The maximal
power of the EAE muscles was considerably lower (by
73%; P  0.05). This was not due only to the lower
muscle mass and force per muscle mass. The force–
velocity relations of the EAE muscles were more
curved, leading to an extra reduction of maximal
power compared to the control group by 35%
(Fig. 2).
Inﬂuence of Stimulation Frequency. Stimulation
frequency–force relationships for the EAE and con-
trol groups are shown in Figure 3. It can be seen that
the stimulation frequency needed to induce maxi-
mal isometric force is shifted to lower frequencies
for the EAE muscles (from 150 Hz for the control
group to 80 Hz for the EAE group). As a conse-
quence, in the EAE group, relative high forces were
obtained at relative low frequencies of stimulation.
The result of this leftward shift is that, although the
maximal force of the EAE muscles was only65% of
that of the control muscles, force generation during
submaximal activation was not reduced.
Fatigue. During a series of 20 repeated isomet-
ric contractions, a fairly linear decrease in force
occurred in both groups to a similar extent (by 32 
4% and 30  6% for the EAE and control groups,
respectively, at the end of the series). Half-relaxation
time increased in both groups, but relatively more in
the control group. As a result the difference in half-
relaxation time between the EAE and control groups
at the beginning of exercise (51  4 ms vs. 40  2
ms) had disappeared at the end of exercise (69  4
ms vs. 69  7 ms).
DISCUSSION
The main results of the present study were: (1) there
was a signiﬁcant loss of body mass, muscle mass, ﬁber
CSA, absolute force and power, and force per muscle
mass in the EAE rats; and (2) there was a slower
relaxation in the EAE muscles, which had the “ad-
vantage” that the stimulation frequency–force rela-
tion was shifted to lower frequencies, such that a
relative high force was maintained at lower stimula-
tion frequencies, which are used in daily-life activi-
ties. This advantage was, however, lost when the
muscles fatigued.
Reduction in Mass and Force. To our knowledge,
there have been reports of reduction in body mass
(e.g., Le Page et al.18), but no previous reports of a
reduction in muscle mass as a consequence of EAE
induction. The loss of body mass started about 10
days after EAE induction, at about the same time as
the tip of tail reﬂex was lost. At the day of measure-
ment, the GM muscle had lost 33% of its mass
(Table 1), indicating that the reduction in body mass
was at least in part a consequence of muscle atrophy.
It is known that skeletal muscles atrophy very fast
when they are not used.14 The force per unit muscle
mass was also considerably lower in the EAE muscles
(by 35%, Table 1, Fig. 1). The occurrence of atro-
phy in the EAE group was conﬁrmed by the ﬁber
CSA data (Table 2). The differences in ﬁber CSA
(40–50%) seemed even more pronounced than
for muscle mass, but even if this larger difference in
FIGURE 3. Stimulation frequency–force relation for medial gas-
trocnemius muscles of EAE and control rats. Mean and standard
deviations for force per gram muscle are presented for the EAE
muscles (n  7; open squares and dashed line) and control
muscles (n  8; ﬁlled circles and solid line). Asterisks indicate
signiﬁcant differences between the groups (P  0.01).
FIGURE 2. Force–velocity and power–velocity relationships for
medial gastrocnemius muscles of EAE and control rats. Fitted
curves are presented for EAE (dashed lines) and control muscles
(solid lines). Force is normalized for the maximal force of each
group. Power is normalized for the maximal power of the control
group.
Muscle Function in Acute EAE MUSCLE & NERVE March 2004 373
CSA is taken into account, normalized force would
still be lower by 25%.
Similar decreases in speciﬁc force have been re-
ported for different forms and degrees of reduced
activity.2,4,15,31 Speciﬁc force of soleus motor units
was shown to decline as a result of chronic spinal
transection in cats.4 Less drastic models of reduced
activity, such as hind-limb unloading31 and aging,2
have also resulted in lower speciﬁc forces. Several
possible mechanisms of the low speciﬁc force after
reduced activity have been suggested. For example,
Kalliainen et al.15 showed that the speciﬁc force
deﬁcit could partially be explained by a subpopula-
tion of noncontractile, denervated ﬁbers. Thompson
et al.31 suggested that decreases in myoﬁbrillar pro-
tein concentration or number of crossbridges per
cross-sectional area are responsible. For human mus-
cle, changes in muscle architecture as a result of
atrophy have been held to explain the reduced spe-
ciﬁc force,2 although Rutherford and Jones28 could
not demonstrate a relation between ﬁber pennation
and speciﬁc force of human quadriceps muscle.
In light of the above-mentioned observations of
decreases in muscle mass and speciﬁc force as a
result of decreased activity, it cannot be concluded
that the reduction in force seen in EAE muscles is
attributable to EAE. In fact, the reduction in muscle
activity alone might explain our result, but a further
direct inﬂuence of EAE on muscle mass and speciﬁc
force is possible.
Slowing of Relaxation. We observed longer half-
relaxation times in GM of the EAE rats (Table 1, Fig.
1). The rate of muscle relaxation is mainly deter-
mined by the kinetics of crossbridge turnover or the
rate of removal of calcium ions from troponin as a
result of the removal of free calcium from the sarco-
plasm by the sarcoplasmic reticulum.32 The maximal
shortening velocity, which reﬂects the maximum
rate of crossbridge turnover,32 was similar in EAE
and control muscles (Table 1, Fig. 2). This suggests
that the slow relaxation in EAE muscles is a conse-
quence of slowing of the rate of calcium uptake by
the sarcoplasmic reticulum.
It is still unclear which mechanism was responsi-
ble for the changes in calcium uptake rate by the
sarcoplasmic reticulum but, whatever the mecha-
nism may be, the result of the slowing of calcium
uptake may be an advantage for the animals. In EAE,
as in MS, it may be that muscle activation is attenu-
ated because of the reduced capacity of axons of
motoneurons in brain and spinal cord to conduct
the action potential to the peripheral nerves and
thus to the muscles. A high ﬁring frequency is
needed to fully activate muscle ﬁbers in isometric
conditions, but even higher frequencies are neces-
sary for maximal dynamic contractions (maximal
power output).8 However, in daily activities, skeletal
muscles are activated submaximally with relatively
low frequencies. The advantage of the slowing of
relaxation is that muscle force may be relatively high
at relatively low frequencies of stimulation (Fig. 3).
In the present study, the submaximal forces at low
frequencies were similar to those of control muscles
despite the lower force per muscle mass and lower
muscle mass. The slow relaxation thus enables the
EAE rats to sustain daily activities such as eating and
drinking. Slow relaxation can, however, also have a
negative effect in exercise with fast repeated stretch-
shortening contractions when relaxation is too slow
to be completed before the muscle is re-stretched for
the next contraction. The muscles of the EAE rats
were much weaker with regard to maximal forces,
and the situation was even worse for maximal power
output (Table 1), so that repeated dynamic activity
would be difﬁcult for these rats.
Signiﬁcance for MS. In the present study, the skele-
tal muscle mass of the hind-limb in EAE rats was
reduced by 30%. Human muscles also show rapid
changes in muscle size and function when muscle
usage is prevented or reduced. For instance, when
muscles were fully immobilized, such as by plaster
casting a leg, 40% loss of thigh volume occurred
within 6 weeks.14 In ambulatory MS patients with
mean expanded disability status scale (EDSS) ratings
of 3.8, however, there was no indication of loss of
adductor pollicis muscle mass,12 and quadriceps
muscle mass was reduced maximally by only 11%.9
We observed a slowing of relaxation in the mus-
cles of EAE rats (Table 1). In ambulatory MS pa-
tients, no signs of slowing in relaxation were found
in quadriceps9 or tibialis anterior muscle.30 How-
ever, for a patient with severe MS, Rice et al.26 re-
ported a slow relaxation and shift in the stimulation
frequency–force relationship in the quadriceps mus-
cle similar to our EAE muscles. A high prevalence of
vitamin D deﬁciency has been reported in MS pa-
tients20 and muscle weakness in vitamin D deﬁciency
may be (partly) attributable to changes in calcium
ﬂuxes in skeletal muscle upon activation.5 Further-
more, vitamin D–depleted rats showed slowing of
relaxation,27 similar to our EAE rats and the severe
MS patient,26 indicating that similar mechanisms
may be involved in the changes in muscle function in
EAE and MS.
It is clear that the results obtained in EAE rats
cannot be translated directly to the situation in all
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MS patients. However, our studies clearly show an
enormous impact of impaired conduction in the
central nervous system on muscle function, which is
in accordance with studies after peripheral denerva-
tion, and supports the fundamental role of activity as
a regulatory signal for muscle contractile proper-
ties.3 Given the fact that in EAE the central conduc-
tion failure is only transient, our data encourage us
to undertake further studies to preserve muscular
activity during EAE, for example, by altering calcium
balance. By such approaches, muscle atrophy may be
reduced and fatigue partly prevented. Also in MS,
certainly at its early stages, neurological deﬁcits are
often transient and further studies on the mecha-
nisms of muscle weakness and fatigue are required
to investigate whether treatments can be designed,
for example, by speciﬁc diets or by training,17 to
prevent wasting of muscles.
In conclusion, the present study showed a loss of
muscle and body mass starting 10 days after EAE
induction. The loss of muscle mass was accompanied
by a reduction in force per muscle mass. Both these
changes may be a result of the sudden inactivity of
muscles due to the neurological lesion. Two to three
days after the time of maximal paralysis, the muscles
showed a slowing of relaxation, which shifted the
stimulation frequency–force relation to lower fre-
quencies. As a consequence, the submaximal force
(at low frequencies) was not lower than control mus-
cles, despite the lower maximal force (only 42%)
due to the reduction in muscle mass and the force
per muscle mass. This advantage of the EAE muscles
was, however, lost after a bout of fatiguing exercise.
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